Services
The commercial outcome.
Who to reach. What to say. Where it lives. What it has to prove.
A market rarely gives you one question at a time. Audience, message, experience, investment, platform, and performance move together. The better the decisions connect, the clearer the path from opportunity to outcome.
That is how jscTEK works. Commercial strategy, brand and creative, digital infrastructure, and analytics operate as one system. We work through fixed-scope projects, ongoing retainers, or phased roadmaps built around the milestone ahead.
01Commercial Strategy
Segmentation and targeting, launch planning and economics, pricing and volume forecasting, territory design, and the investment case behind the spend.
Explore
02Brand and Creative
The brand system everything downstream inherits from. Identity and messaging, then the field materials and the interface design, all of it built for regulatory review.
Explore
01Commercial Strategy
The business case, before the campaign.
A board asks what the launch returns, and the room has an estimate where a model should be. We build it before anything else: what the launch costs, what it has to clear, how the territory gets covered, and what price the market carries. Here the firm that built the model also builds the platform and reports against the same number.
Launch economics, revenue and volume forecasting, pricing and profitability, and the business case and ROI model behind them.
Territory design and coverage planning, pipeline structure, forecasting discipline, and win-loss analysis.
Segmentation and physician targeting from claims and utilization data, and the investor reporting behind a board decision.
For Zionexa, a physician targeting analysis built from federal claims data became the market entry model for two markets, and the company was launch-ready in both.
02Brand and Creative
Brands that earn authority.
A milestone is on the calendar, and the brand has to be ready for it. In regulated and technical markets the brand has to do more than look credible. It has to make complex value clear, and it is built for regulatory review, investor scrutiny, and diligence.
Identity and visual systems built for regulated and investor contexts, and the messaging and positioning they rest on.
Sales materials and leave-behinds, physician and patient brochures, clinical and evidence materials, and investor and board presentations.
Physician and patient sites, content structure and navigation, and the full layout brief before any build begins.
For Neuraceq, one message had to hold with nuclear medicine and neurology and survive review. It did, and the field and product page make the same argument.
03Digital Infrastructure
One team builds it. The same team runs it.
The website is the foundation, and in a company with a handful of people in the field, the website is the field team. It has to answer the questions the field is being asked, connect a physician to the right resource, and keep working as the business scales. We design, build, host, and maintain it, and everything that attaches to it, with one accountable team.
Enterprise WordPress and Avada builds, FDA-compliant launch sites, multi-market routing, hosting, security monitoring, and uptime.
Technical SEO, Core Web Vitals, site performance, accessibility compliance, and ongoing maintenance.
Gated programs with license verification, case and molecule libraries, locators, and CRM, on sites we already run.
For SOFIE, a platform built and hosted by the same team, with locations, news, and events added in house. Website traffic quadrupled, and the platform was built to carry it.
04Analytics and Intelligence
Decisions you can defend.
At some point someone will ask what the spend bought. Measurement matters when it changes what you do next, so we put the tracking in at build, then report commercial performance, ROI, channel contribution, and market signals against the same plan that justified the investment.
Performance reporting, executive dashboards, and board reporting tied to the milestones that were approved.
Return on funded initiatives, and attribution modeling across programs and channels.
Competitive and market intelligence, with conversion tracking and data integrity put in at build.
For IONETIX, a rebrand and a clinical case library measured from the day the campaign went live. Web and social engagement grew 30 percent.